A detailed history of Wilen Investment Management Corp. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wilen Investment Management Corp. holds 12,638 shares of BMY stock, worth $729,970. This represents 0.91% of its overall portfolio holdings.

Number of Shares
12,638
Previous 12,638 -0.0%
Holding current value
$729,970
Previous $967,000 7.86%
% of portfolio
0.91%
Previous 0.84%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 04, 2022

SELL
$61.48 - $73.72 $6,148 - $7,372
-100 Reduced 0.79%
12,638 $916,000
Q4 2021

Feb 02, 2022

SELL
$53.63 - $62.52 $5,363 - $6,252
-100 Reduced 0.78%
12,738 $790,000
Q2 2021

Aug 13, 2021

BUY
$61.91 - $67.42 $272,404 - $296,648
4,400 Added 52.15%
12,838 $854,000
Q4 2020

Feb 11, 2021

BUY
$57.74 - $65.43 $86,610 - $98,145
1,500 Added 21.62%
8,438 $519,000
Q3 2020

Nov 16, 2020

BUY
$57.43 - $63.64 $398,449 - $441,534
6,938 New
6,938 $437,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Wilen Investment Management Corp. Portfolio

Follow Wilen Investment Management Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilen Investment Management Corp., based on Form 13F filings with the SEC.

News

Stay updated on Wilen Investment Management Corp. with notifications on news.